CompoAtlas

oemine GAST GINGEMBRE GENTIANE E

Food supplement declared in France, declaration No 2023-1-1486, decision dated 27 January 2023

oemine GAST GINGEMBRE GENTIANE E (oemine) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
oemine
Food business operator placing the product on the market
PHYTOBIOLAB
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules
Directions for use
2 gélules avant chaque repas
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 191615, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Zingiber officinale RoscoeRacineExtrait sec aqueux2,136 mg
Gentiana lutea L.RacineExtrait sec aqueux480 mg

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé chez les personnes ayant un traitementpar anticoagulants et en cas d'allergie au gluten

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : oemine

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line